AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Shares Shorted: Short Interest Down 66.2% in October

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 30th, there was short interest totaling 469,259 shares, a decrease of 66.2% from the October 15th total of 1,388,145 shares. Approximately 1.7% of the shares of the stock are sold short. Based on an average daily volume of 1,505,842 shares, the short-interest ratio is presently 0.3 days.

Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

A number of hedge funds have recently modified their holdings of BTAL. Crescent Grove Advisors LLC purchased a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund in the first quarter worth approximately $6,614,000. Collaborative Fund Advisors LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund during the 3rd quarter worth $1,794,000. Farther Finance Advisors LLC boosted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 939.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 42,356 shares of the company’s stock valued at $508,000 after purchasing an additional 38,282 shares during the period. Bank of New York Mellon Corp lifted its position in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the first quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after purchasing an additional 10,146 shares during the period. Finally, CoreCap Advisors LLC acquired a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter worth approximately $36,000.

AGF U.S. Market Neutral Anti-Beta Fund Stock Up 1.8%

NYSEARCA:BTAL opened at $13.26 on Friday. AGF U.S. Market Neutral Anti-Beta Fund has a 52-week low of $10.86 and a 52-week high of $16.14. The business’s 50-day moving average price is $12.56 and its 200 day moving average price is $12.65. The firm has a market cap of $379.90 million, a P/E ratio of 17.49 and a beta of -0.68.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

Further Reading

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.